Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

Deer Antler Velvet: The Definitive Guide

Older trials do not support broad performance, sexual-function or rheumatoid-arthritis claims. One current product changed immune biomarkers, without proving fewer infections or better health.

Critical evidence snapshot for Deer Antler Velvet

Deer Antler Velvet: human protocols, outcomes, boundaries and risks.

Deer Antler Velvet

animal tissue • variable products

7 RCTsmostly null review
300–480 mgspecific extract, 8 weeks
4 of 6products with detected IGF-1

Read beyond the claim

  1. 1

    Product

    Species, form and lot

  2. 2

    Protocol

    Exact amount and duration

  3. 3

    Endpoint

    Clinical outcome or marker

Evidence

Product-specific

Dose

Source-specific

Safety

Product-specific risk

Decision

Track the real endpoint

Numbers come from specific sources and do not define a personal dose.
Published by DoserlyUpdated Next scheduled review: April 20277 min readHow this guide was made
In this guide

What is Deer Antler Velvet?

Deer antler velvet is tissue harvested from growing, unossified antlers and sold as ground powder, extracts, capsules, tinctures or sprays. Species, harvest stage, extraction, digestion and finished-product testing can change composition. A trial of one named enzymatic extract does not validate every velvet product. [1], [4]

Typical Deer Antler Velvet Protocols

Amount each administration and daily total are separated without inferring missing details.
Source and questionPreparationAmount each administrationDaily totalFrequency and durationMain interpretation
Kim 2025 · immune-biomarker RCT · 120 adultsYHC-BE-2040 enzyme-digested C. elaphus extractHigh: 480 mg across 2 capsules; low: 300 mg across 2 capsules480 mg/day or 300 mg/dayTwo capsules once each morning after a meal for 8 weeksNK-cell activity and IFN-γ signals; other cytokines null, five discontinued, and no clinical infection endpoint
Conaglen 2003 · sexual-function RCT · 32 menGround deer velvet capsules versus placeboAmount per administration not reported in abstractDaily total not reported in abstractDaily for 12 weeksNo between-group sexual-function advantage and no significant hormone changes
Sleivert 2003 · training RCT · 38 active menVelvet extract, velvet powder or placeboAmount per administration not reported in abstractDaily total not reported in abstractSupplementation plus 10-week strength program; administration schedule not reported in abstractNo endocrine, red-cell-mass or VO₂max effect; isolated powder strength/endurance signals may be type-I error
Allen 2008 · rheumatoid-arthritis RCT · 168 enrolledElk velvet antler versus placebo alongside standard treatmentAmount per administration not reported in abstractDaily total not reported in abstractSix months; administration schedule not reported in abstractNo significant between-group difference in pain, swelling, function, quality of life, CRP or global assessment
Exact product
Record species, form, lot and co-ingredients.
Each administration
Keep amount, timing and context.
Real endpoint
Separate biomarker, symptom and clinical outcome.

What is it commonly used for?

Products are marketed for strength, endurance, recovery, sexual function, joints and immunity. A systematic review found seven randomized trials: two had unconvincing positive findings and five were null. Trials in sexual function and rheumatoid arthritis were negative. A 2025 trial of YHC-BE-2040 changed natural-killer-cell activity and interferon-gamma, but measured biomarkers rather than infections or durable clinical benefit. [1], [2], [4]

Evidence boundary

One result answers one question

ProductExact formulation
PopulationWho was actually studied
EndpointClinical outcome or marker
One specific product, population and endpoint do not create a universal claim. Sources: Primary human evidence.

How do forms and labels differ?

Whole powder, aqueous or alcohol extracts, enzyme-digested extracts, capsules and oral sprays are not interchangeable. Analytical testing detected human IGF-1 in four of six commercial products, showing why a label alone cannot define exposure. Record species, tissue, extraction ratio, standardization and independent batch testing. [4], [5]

How should the product be stored?

Follow the finished product’s label, keep it dry in its original container and away from children. Discard an expired, heat-damaged, broken-seal or untraceable product.

What does human research show?

Doserly diagram distinguishing mechanisms, biomarkers, symptoms, function and clinical outcomes.
A mechanism or biomarker does not guarantee clinical benefit.
QuestionBest direct evidenceFindingBoundary
EfficacyKim 2025 · immune-biomarker RCT · 120 adultsNK-cell activity and IFN-γ signals; other cytokines null, five discontinued, and no clinical infection endpointSpecific product and population
ReplicationLimited evidenceNo universal effect establishedVariable formulations
Universal dose?NoneNot establishedRows cannot be combined
Label check

Keep the finished product reviewable

IdentitySource and form
ExposureEach administration and total
IntegrityLot and independent testing
A front label is insufficient: retain form, lot, testing and co-ingredients. Sources: Official context.

What are the risks and interactions?

Long-term safety is poorly characterized. Animal-derived material raises product-integrity, contamination and allergy questions. People with hormone-sensitive conditions, pregnancy, breastfeeding, childhood use or active immune disease need conservative clinical review. Athletes face an additional anti-doping boundary because IGF-1 is prohibited and product content cannot be inferred from the ingredient name. [2], [3], [5], [6]

Seek urgent care for breathing difficulty, throat or tongue swelling, faintness, widespread hives, repeated vomiting or suspected overdose.

What is the legal and regulatory status?

In the United States, it is sold as a dietary supplement; FDA does not approve it for safety and effectiveness before sale. In Canada, verify the exact product, NPN and authorized label. Legal sale does not prove efficacy or sport suitability. [6]

When should use stop?

Stop for any allergic reaction, persistent symptom worsening, unexpected laboratory result or doubt about product identity.

What should be monitored?

Record exact product, species, extract or powder, lot, amount per administration, daily total and training or symptom context. Choose a clinical outcome before starting. Immune-cell activity, testosterone, IGF-1, strength, fatigue and infection frequency are different endpoints and should not be collapsed into one wellness score.

What can community experience add?

Reports can identify odor, capsule burden, cost and product-form questions. They cannot verify IGF-1 content, establish recovery or explain joint disease. No systematic current community sample was assembled, so no consensus cycle or stack is reported.

How do related options compare?

OptionMain distinction
Whole powderGround tissue; variable composition and digestion
Enzyme-digested extractSpecific formulation tested in 2025
Oral sprayExposure cannot be inferred from capsule trials

Common questions

Does it improve strength?

Findings are inconsistent, and the systematic review judged positive signals unconvincing.

Does it raise testosterone?

The sexual-function trial found no significant hormone change.

Does the immune biomarker prove fewer infections?

No. The current trial did not measure a clinical infection benefit.

What dose is proven?

No universal dose. The 300 and 480 mg/day amounts belong to one named enzyme-digested extract.

Is it allowed for a tested athlete?

Velvet itself is not named as prohibited, but IGF-1 is and may be present; check current rules and do not assume zero risk.

Can it replace arthritis treatment?

No. The rheumatoid-arthritis trial was null, and prescribed treatment should not be stopped.

Glossary

Terms for reading the evidence.

Endpoint
A defined result measured in a study.
Anaphylaxis
A potentially life-threatening systemic allergic reaction.
Biomarker
A biological measure that does not guarantee clinical benefit.
Standardization
A measured specification for a product component.
Cross-reactivity
Immune recognition of related proteins from different sources.

How this guide was researched

NCBI identities, publication notices, indexed abstracts and available open methods were checked. Null outcomes, mixed products, surrogate endpoints and missing details remain visible.

Research record · checked October 9, 2026

Identity: every PMID/PMCID was checked through NCBI EFetch for title, first author, journal, DOI and publication notices. No linked notice was found.

Methods: open methods for PMC4486804 or PMC11922470 were read as applicable. Amounts absent from abstracts were not inferred.

Boundary: null outcomes and surrogate endpoints remain visible. No systematic current community sample was assembled.

Explore the sources

Primary human evidence and official context.

Showing 6 sources

  1. 01

    Health benefits of deer and elk velvet antler supplements: a systematic review of randomised controlled studies. ↗

    Systematic review of randomized trials

    Seven trials across arthritis, sexual function and performance; five null and two positive findings judged unconvincing.

  2. 02

    Efficacy and safety of YHC-BE-2040 on immune function: An 8-week, multicenter, randomized, double-blinded, and placebo-controlled study. ↗

    Randomized double-blind trial

    One hundred twenty adults; 300 or 480 mg/day once each morning for eight weeks; biomarker signals without a clinical infection endpoint.

  3. 03

    A randomized clinical trial of elk velvet antler in rheumatoid arthritis. ↗

    Randomized triple-blind trial

    One hundred sixty-eight enrolled for six months; no significant difference on any reported disease, function or quality-of-life measure.

  4. 04

    Effect of deer velvet on sexual function in men and their partners: a double-blind, placebo-controlled study. ↗

    Randomized double-blind trial

    Thirty-two men used daily capsules for 12 weeks; sexual function and sex-hormone outcomes were null.

  5. 05

    Detection of human insulin-like growth factor-1 in deer antler velvet supplements. ↗

    Analytical product study

    Human IGF-1 was confirmed in four of six commercial products; this was an analytical study, not an efficacy trial.

  6. 06

    Deer Antler Velvet in Dietary Supplements ↗

    Official military supplement guidance

    Explains limited evidence, uncertain IGF-1 content and the distinction between the ingredient and prohibited IGF-1 exposure.

Editorial note

This guide separates composition, biomarker, symptom and clinical outcome. It does not turn a narrow signal into a general promise.